NCT02488486

Brief Summary

This pilot study evaluates the effectiveness of a closed-loop administration of propofol and remifentanil guided by the bispectral index for short-term sedation after cardiac surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 26, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 2, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

May 17, 2017

Status Verified

May 1, 2017

Enrollment Period

2 years

First QC Date

June 26, 2015

Last Update Submit

May 16, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Level of sedation

    Richmond Agitation-Sedation Scale measured until extubation

    6 hours

Secondary Outcomes (20)

  • Level of pain during sedation

    6 hours

  • Changes in hemodynamics profile consecutive to a tracheal suctioning

    6 hours

  • Changes in Bispectral Index consecutive to a tracheal suctioning

    6 hours

  • Changes in Richmond Agitation-Sedation Scale consecutive to a tracheal suctioning

    6 hours

  • Changes in Behavioral Pain Scale consecutive to a tracheal suctioning

    6 hours

  • +15 more secondary outcomes

Study Arms (1)

Automated postoperative sedation

EXPERIMENTAL

Postoperative sedation is provided automatically using a closed-loop system. Bispectral index is used as the input signal and an algorithm defines the appropriate concentrations of propofol and remifentanil. Adequate postoperative sedation is defined by a bispectral index between 40 and 60.

Device: Automated postoperative sedationDrug: propofolDrug: remifentanil

Interventions

Also known as: algorithm is the property of Medsteer SAS
Automated postoperative sedation
Automated postoperative sedation
Automated postoperative sedation

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • consent for participation
  • cardiac surgical procedure requiring postoperative sedation

You may not qualify if:

  • pregnant women,
  • neurological or muscular disorder
  • high risk of revision surgery
  • patients having required a redo operation if the postoperative period of sedation was less than 2 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Ambroise Paré

Neuilly-sur-Seine, Hauts-de-Seine, 92200, France

Location

Related Publications (1)

  • Le Guen M, Liu N, Bourgeois E, Chazot T, Sessler DI, Rouby JJ, Fischler M. Automated sedation outperforms manual administration of propofol and remifentanil in critically ill patients with deep sedation: a randomized phase II trial. Intensive Care Med. 2013 Mar;39(3):454-62. doi: 10.1007/s00134-012-2762-2. Epub 2012 Dec 6.

    PMID: 23223772BACKGROUND

MeSH Terms

Interventions

PropofolRemifentanil

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsPropionatesAcids, AcyclicCarboxylic AcidsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2015

First Posted

July 2, 2015

Study Start

May 1, 2015

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

May 17, 2017

Record last verified: 2017-05

Locations